SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.05-0.4%Dec 29 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (13792)1/27/1998 2:00:00 PM
From: Proton  Read Replies (1) of 32384
 
Re: Where to be in January

Too bad the merger is not helping LGND any.

Here are some YTD numbers to ponder:

Drug Index +8.1%
Biotech Index -2.9%
Ligand Pharm. -7.8%

To go back to Shakespeare, we can hope that, "The cat will mew, and
the dog shall have his day." Right now, though, a lot of money that
might have run after biotechs is finding better pickings in the drug
group. You can bet that is going to include institutions.

Indeed, ethical drug merger mania may be hurting LGND. It's hard to
argue with a 16% disparity in performance (or even the 5% underperformance
relative to the BTK... but we can just call that the droloxifene
effect. :-O )

"The droloxifene news is a disappointment and creates a question about
the drug's potential for the other two indications Pfizer is still
pursuing," said A.G. Edwards drug analyst Kenneth Nover.


Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext